General Information
Revision date
2006-07-14
Product name
Velocity SG Herbicide
CAS No.
125401-92-5
Manufacturer Name
VALENT USA CORPORATION
Emergency telephone
HEALTH EMERGENCY OR SPILL (24 hr
Icons in SDS
Company Information
company name
VALENT USA CORPORATION
Section 2
SECTION 2: Hazards identification
EMERGENCY OVERVIEW CAUTION • May cause eye irritation. • Avoid contact with eyes, skin and clothing. • Keep out of reach of children.
Potential health effects
Acute Toxicity (Primary Routes of Exposure) Signs and Symptoms of Systemic Effects: Signs of toxicity observed in test animals exposed to repeated high doses of a similar product, bispyribac-sodium technical, include vomiting, salivation, loose stools and decreased body weight gain. Acute Eye Contact: This product can cause brief and/or minor eye irritation. The expected adverse health effects resulting from an exposure may include redness and possible swelling. Acute Skin Contact: This product can cause brief and/or minor irritation. The expected adverse health effects resulting from an exposure may include redness and possibly some minor swelling. This product is minimally toxic when absorbed through the skin. This product is not expected to cause allergic skin reactions. Acute Ingestion: This product is minimally toxic when ingested. Acute Inhalation: This product is minimally toxic when inhaled. Chronic Toxicity (including cancer): Studies with bispyribac-sodium technical in laboratory animals indicate that repeated high exposures can produce changes in the liver, urinary bladder, bile duct and kidney but do not produce cancer. Developmental Toxicity (birth defects): No developmental toxicity was produced in laboratory animals exposed to bispyribac-sodium technical, even at doses that were toxic to the pregnant animal. Reproductive Toxicity: Bispyribac-sodium technical did not produce reproductive toxicity in animal studies. Potentially Aggravated Medical Conditions: Individuals with preexisting conditions of the liver, kidney, bile duct or urinary bladder may have increased susceptibility to the toxicity of excessive exposures For complete discussion of the toxicology data from which this evaluation was made, refer to Section 11. For Regulatory Information, refer to Section 15.